Rotavirus

Immunity Achievable Through Microencapsulation

Published in Vaccine Weekly, October 16th, 1995

Microencapsulation may be an efficient way of inducing virus-specific immune responses against rotaviruses in gut-associated lymphoid tissues (GALT), according to a report from Philadelphia, Pennsylvania's Temple University.

Rotaviruses are the major cause of acute diarrheal disease in infants and young children and cause an estimated 830,000 deaths per year.

Development of a successful vaccine is a top priority of the World Health Organization (WHO). Vaccine strategies currently in use include oral inoculation of infants with animal, human, or animal plus human reassortant rotaviruses. A vaccine that consistently protects against rotavirus disease...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-10-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry